French innovation consultancy providing business models and governance frameworks to large EU research consortia in urban energy and health.
ALGOE SA is a French management and innovation consulting SME based near Lyon that brings business modeling, governance design, and co-creation methodology to large-scale EU research consortia. Their core contribution is translating complex technical or scientific work into viable business cases, scalable operating models, and citizen- or patient-centered frameworks. In SMARTER TOGETHER they worked on bankability protocols, business models for smart urban districts, and inclusive governance for city-scale energy transitions. In ONCOBIOME they applied similar commercialization and strategy expertise to precision oncology, helping convert microbiome research findings into diagnostic and prophylactic pathways.
Both SMARTER TOGETHER and ONCOBIOME list business model, governance, and integration-type keywords, indicating ALGOE provides this function across very different technical domains.
SMARTER TOGETHER (2016–2021) involved data platforms, low-energy districts, district heating, e-mobility, and bankability protocols for large-scale urban demonstrators.
SMARTER TOGETHER keywords include 'citizen focus', 'cocreation', and 'inclusive', pointing to structured participatory design as a service ALGOE provides.
ONCOBIOME (2019–2025) covers cancer diagnostics, immunotherapy, and prophylactic measures — ALGOE's role is likely commercialization or governance, not the science itself.
In their first H2020 project (2016), ALGOE operated squarely in the smart city and energy transition space — focused on governance structures, data platforms, bankability, and scalable business models for urban low-energy districts. By 2019 their involvement shifted entirely to oncology research (ONCOBIOME), working alongside cancer biologists on microbiome signatures, precision medicine, and immunotherapy — a complete domain change. The consistent thread across both periods is not a technical discipline but a functional one: bringing business modeling, governance, and integration expertise to consortia that are strong in science but need structured pathways to impact.
ALGOE appears to be repositioning from urban energy consulting toward health and life sciences, suggesting they are actively expanding their consultancy offering into the biomedical sector — a high-growth area for EU-funded innovation management.
ALGOE participates exclusively as a consortium partner and has never led an H2020 project, which is consistent with a specialist consultancy that adds governance and business modeling capacity without taking on project coordination risk. Despite only two projects, they have connected with 75 unique partners across 13 countries, reflecting participation in very large demonstrator and research consortia rather than small focused teams. This means working with them typically means joining their network indirectly — they are well-connected but not a hub that pulls others together.
With 75 unique partners across 13 countries from just two projects, ALGOE has embedded itself in two large, geographically diverse European consortia. Their network spans Western and Southern Europe at minimum, consistent with participation in flagship EU demonstrator projects.
ALGOE is unusual in that it operates as a domain-agnostic governance and business model consultancy — it moved from smart cities to cancer research without changing its core function, which suggests strong transferable methodology rather than sector-specific knowledge. For consortium builders, this makes them a flexible partner to bring structured business thinking into technically complex projects where commercialization pathways are weak. Their SME status and French base near Lyon also make them eligible for SME-specific funding roles while contributing senior consultancy-level output.
